These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23884983)

  • 41. [Severe mitral regurgitation as the first symptom of systemic lupus erythematosus in a young women required mitral valve replacement].
    Nowicka A; Piątkowska A; Biegalski W; Dankowski R; Michalski M; Szymanowska K; Szyszka A; Jemielity M; Seniuk W; Sosnowski P
    Kardiol Pol; 2012; 70(4):421-3. PubMed ID: 22528724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment.
    Nesher G; Ilany J; Rosenmann D; Abraham AS
    Semin Arthritis Rheum; 1997 Aug; 27(1):27-35. PubMed ID: 9287387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A survivor of late prosthesis migration and rotation following percutaneous transcatheter aortic valve implantation.
    Pang PY; Chiam PT; Chua YL; Sin YK
    Eur J Cardiothorac Surg; 2012 May; 41(5):1195-6. PubMed ID: 22228843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double valve replacement in a patient with osteogenesis imperfecta.
    Chrysant GS; Cassivi SD; Carey CF; Sundt TM
    J Heart Valve Dis; 2002 Sep; 11(5):751-4. PubMed ID: 12358415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcatheter aortic valve replacement: current developments, ongoing issues, future outlook.
    Tang GH; Lansman SL; Cohen M; Spielvogel D; Cuomo L; Ahmad H; Dutta T
    Cardiol Rev; 2013; 21(2):55-76. PubMed ID: 23269035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.
    Hojnik M; George J; Ziporen L; Shoenfeld Y
    Circulation; 1996 Apr; 93(8):1579-87. PubMed ID: 8608627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment by transcatheter aortic valve implantation of severe aortic regurgitation in a patient with ascending aorta prosthesis.
    Rossi ML; Bocchi R; Barbaro C; Pagnotta P; Mennuni M; Zavalloni D; Gasparini G; Presbitero P
    Heart Lung Circ; 2013 May; 22(5):383-5. PubMed ID: 23164807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcatheter aortic valve implantation outcomes: implications for practice.
    McRae ME; Rodger M
    J Cardiovasc Nurs; 2012; 27(3):270-82. PubMed ID: 21760524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Foreword. An update on transcatheter aortic valve replacement.
    Rahimtoola SH
    Curr Probl Cardiol; 2013 Jul; 38(7):243. PubMed ID: 23746945
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
    Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
    Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement.
    Fox H; Büttner S; Hemmann K; Asbe-Vollkopf A; Doss M; Beiras-Fernandez A; Moritz A; Zeiher AM; Scheuermann E; Geiger H; Fichtlscherer S; Hauser IA; Lehmann R
    J Cardiol; 2013 Jun; 61(6):423-7. PubMed ID: 23611171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitral valve surgery in patients with systemic lupus erythematosus.
    Foroughi M; Hekmat M; Ghorbani M; Ghaderi H; Majidi M; Beheshti M
    ScientificWorldJournal; 2014; 2014():216291. PubMed ID: 25401131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aortic valve replacement for Libman-Sacks endocarditis.
    Keenan JB; Rajab TK; Janardhanan R; Larsen BT; Khalpey Z
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27702929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?
    Amigo MC
    Lupus; 2014 Oct; 23(12):1259-61. PubMed ID: 25228720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome.
    Sakaguchi G; Minami K; Nakayama S; Tsuneyoshi H
    Jpn J Thorac Cardiovasc Surg; 1998 Mar; 46(3):257-9. PubMed ID: 9584474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.